Advisory Board February 2, 2024

The Biden administration on Thursday sent pharmaceutical companies initial offers for 10 drugs that will be part of Medicare’s new drug price negotiation program under the Inflation Reduction Act (IRA). However, the program is the subject of several ongoing lawsuits filed by drug manufacturers that have argued the law is unconstitutional.

Background

The IRA, which was signed into law in August 2022, includes several drug pricing provisions. Under the law, Medicare will be able to negotiate certain prescription drug prices with pharmaceutical companies. This provision will initially apply...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, HHS, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article